Contents:
Document Title
Clinical Guideline for Primary Prophylaxis for Venous Thromboembolism(VTE) in the palliative care setting
Document Date
March 2024
Document Purpose and Intended Audience
For use by palliative medicine specialists
Author
Dr Anna Lock
Dr Nadia Khan
Dr Laura Holtham
Consultation Process
Version 3.2 reviewed March 2024. Nil amendments agreed in consultation with SPAGG membership group according to professional opinion and feedback
Monitoring
This will be audited and reviewed every 3 years
Review Date
(must be within three years)
March 2027
Approval Signatures:
SPAGG chair
Dr Jon Tomas
SPAGG secretary
Dr A. Martin
Date Approved by SPAGG: March 2024
Date submitted to Area Prescribing Committee: N/A
Version History
Version 1.0
Date
April 2008
Summary of change/ process
- Endorsed and approved by Governance Committee
Version 1.1 - 1.6
Date
June 2011 - August 2011
Summary of change/ process
- Updated by Anna Lock
- Re-circulated to and approved by SPAGG on behalf of the
- Supportive and Palliative Care NSSG
- Reformatted by Lara Barnish
- With changes by Anna Lock
- Circulated to and presented at SPAGG
- Presented at the Clinical Governance Sub Group
- With minor amendments from the Sub Group, for the attention
of Anna Lock
Version 2.0
Date
August 2011
Summary of change/ process
With comments from Anna Lock
Version 3.0
Date
November 2013 - December 2014
Summary of change/ process
- Updated by Nadia Khan and Anna Lock, circulated to SPAGG
- Audit of regional practice against v2.0, with outcomes informing v3.0
- Endorsed and approved by the SPAGG committee
Version 3.1 - 3.2
Date
March 2017
Summary of change/ process
- Reviewed by Dr Louisa Nelms, endorsed and approved by SPAGG
- With changes from Dr Laura Holtham (March 2020)
Version 3.3
Date
March 2024
Summary of change/ process
Reviewed by Dr Nial McCarron and Dr Ben Lambert, endorsed and approved by SPAGG
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.